🇺🇸 EC naproxen in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised EC naproxen on 14 October 1994

Marketing authorisation

FDA — authorised 14 October 1994

Application: NDA020067
Marketing authorisation holder: ATNAHS PHARMA US
Local brand name: EC-NAPROSYN
Indication: TABLET, DELAYED RELEASE — ORAL
Status: approved

Read official source →

Frequently asked questions

Is EC naproxen approved in United States?

Yes. FDA authorised it on 14 October 1994.

Who is the marketing authorisation holder for EC naproxen in United States?

ATNAHS PHARMA US holds the US marketing authorisation.